As private company pivots to new therapy, U will continue to refine the cancer treatment in Minnesota
- Posted on May 9, 2025
- By Star Tribune
- 3 Views
As private company pivots to new therapy, U will continue to refine the cancer treatment in Minnesota
U researchers had used CRISPR gene editing to deactivate a gene called CISH in tumor-fighting white blood cells and improve their ability to recognize and attack cancer.
